Overview

Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults

Status:
Not yet recruiting
Trial end date:
2022-06-08
Target enrollment:
Participant gender:
Summary
This is a study to determine the relative bioavailability of inhaled epinephrine compared with 0.3mg epinephrine administered IM in healthy male and female participants.
Phase:
Phase 1
Details
Lead Sponsor:
De Motu Cordis
Collaborator:
Novotech (Australia) Pty Limited
Treatments:
Epinephrine
Epinephryl borate
Racepinephrine